PCORI awards $208 million to fund 17 new comparative clinical effectiveness research studies

FHS
July 18, 2023
4:17 pm

The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $208 million to support 17 new comparative clinical effectiveness research (CER) studies, including four trials of particularly large scale and scope tackling complex questions.

Novel Therapy Promising for Radiation-Induced Oral Mucositis

The first-in-class uridine phosphorylase inhibitor TK-90 almost completely eliminated severe oral mucositis (SOM) in patients with non-metastatic squamous cell carcinoma of the head and neck

March 5, 2024

Pregnant smokers who use e-cigarettes more likely to quit smoking later in pregnancy

The risks of smoking during pregnancy for both maternal and fetal health are well documented, but only about half of pregnant people quit smoking on

September 13, 2023

Mid-Stage Win for Novel IgA Nephropathy Drug

PHILADELPHIA — An investigational humanized IgG2 monoclonal antibody reduced proteinuria in adults with immunoglobulin A (IgA) nephropathy at high risk for disease progression despite standard

November 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.